Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Selenium Micronutrient Network WP15,3.5408225776450487e-07,5.884137931034482,87.40143485291627,"['SERPINA3', 'GPX4', 'DIO3', 'PLG', 'KMO', 'SELENOH', 'SELENOM', 'PRDX5', 'RFK', 'IL1B', 'SELENOW', 'SELENOV', 'CCL2', 'SEPHS2', 'XDH']",0.00013490534020827637,0,0,15
2,Cori Cycle WP1946,0.00025544111592299074,11.6421768707483,96.31012518434773,"['LDHA', 'TPI1', 'PGAM1', 'ALDOA', 'GAPDH']",0.028282682839983954,0,0,5
3,Complement and Coagulation Cascades WP558,0.00029505285087607464,4.779256311404054,38.8474970114117,"['C1QB', 'C1QA', 'SERPINA1', 'VWF', 'CFH', 'SERPIND1', 'MASP2', 'PLG', 'C1QC']",0.028282682839983954,0,0,9
4,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.00029693105343815175,3.649279292136435,29.63948505447189,"['NDUFB10', 'UQCRQ', 'NDUFA4', 'NDUFS5', 'NDUFA1', 'ATP5MC3', 'UQCR11', 'UQCR10', 'SLC25A5', 'COX7A1', 'ATP5MF', 'ATP5MC1']",0.028282682839983954,0,0,12
5,"GPCRs, Class A Rhodopsin-like WP455",0.0009418232532633052,2.624270756867442,18.285112799620535,"['GPR65', 'GPR87', 'HTR2B', 'GPR4', 'GPR3', 'SSTR1', 'GPR6', 'MCHR1', 'HCRTR1', 'OPN1SW', 'OR7A5', 'RHO', 'ACKR4', 'OR7C1', 'DRD3', 'GPR18']",0.05664810609485637,0,0,16
6,Oxidative phosphorylation WP623,0.0010961822072201675,4.341339433218961,29.59023033070927,"['ATP6AP1', 'NDUFB10', 'NDUFA4', 'NDUFS5', 'ATP6AP2', 'ATP5MC3', 'ATP5MF', 'ATP5MC1']",0.05664810609485637,0,0,8
7,Computational Model of Aerobic Glycolysis WP4629,0.001107471878935463,11.627717391304348,79.13447076451226,"['LDHA', 'TPI1', 'ALDOA', 'GAPDH']",0.05664810609485637,0,0,4
8,Pre-implantation embryo WP3527,0.0013364286994855489,4.800176550838616,31.76638935804154,"['EGR1', 'ZFP36', 'SIX3', 'GATA2', 'KLF4', 'AQP3', 'TBX3']",0.05664810609485637,0,0,7
9,Spinal Cord Injury WP2431,0.001338144238461174,3.0186104218362284,19.9725498907207,"['SELP', 'C1QB', 'EGR1', 'ZFP36', 'FCGR2A', 'IL1B', 'CDK2', 'CCL2', 'CXCL1', 'MIF', 'LILRB2', 'PDYN']",0.05664810609485637,0,0,12
10,Complement system WP2806,0.0016784855821327157,3.3373776908023483,21.325387329204453,"['SELP', 'PRNP', 'FCGR3A', 'CD93', 'CFH', 'ICAM2', 'MASP2', 'PLG', 'VSIG4', 'SELE']",0.061760590353974604,0,0,10
11,Mitochondrial CIV Assembly WP4922,0.0017831141572013666,5.375602599035841,34.02430638946833,"['COA3', 'PET100', 'NDUFA4', 'SCO2', 'COX14', 'HIGD1A']",0.061760590353974604,0,0,6
12,Mitochondrial complex III assembly WP4921,0.002765362832039629,8.4550395256917,49.805115725435364,"['UQCC3', 'UQCRQ', 'UQCR11', 'UQCR10']",0.08104640300054605,0,0,4
13,Platelet-mediated interactions with vascular and circulating cells WP4462,0.002765362832039629,8.4550395256917,49.805115725435364,"['SELP', 'IL1B', 'CCL2', 'SELE']",0.08104640300054605,0,0,4
14,HIF1A and PPARG regulation of glycolysis WP2456,0.003390612982585802,13.936770691994573,79.25485482070067,"['LDHA', 'TPI1', 'GAPDH']",0.09227311045465647,0,0,3
15,Oxidative Damage WP3941,0.004402097423177825,4.366144414168938,23.68927694665615,"['C1QB', 'C1QA', 'CDKN1A', 'CYCS', 'TNFRSF1B', 'C1QC']",0.10830522770344847,0,0,6
16,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.004548251032165815,5.288188002473717,28.51926404437848,"['EGR2', 'RAB3A', 'HSPB1', 'NEFL', 'RABAC1']",0.10830522770344847,0,0,5
17,Nonalcoholic fatty liver disease WP4396,0.005137590881387896,2.4123272417632804,12.715789422229927,"['NDUFB10', 'NDUFB11', 'NDUFA4', 'NDUFA1', 'UQCR11', 'UQCR10', 'COX7A1', 'SOCS3', 'UQCRQ', 'NDUFS5', 'IL1B', 'CYCS', 'CCL2']",0.11514247798875225,0,0,13
18,Complement Activation WP545,0.005616031040899633,6.642080745341615,34.42012645775405,"['C1QB', 'C1QA', 'MASP2', 'C1QC']",0.11887265703237558,0,0,4
19,Kynurenine Pathway and links to Cellular Senescence WP5044,0.006883868339359438,6.198913043478261,30.86175056973629,"['CDKN1A', 'IL1R2', 'KMO', 'ACMSD']",0.13803967564715505,0,0,4
20,Apoptosis Modulation and Signaling WP1772,0.009153083029773083,2.725727077300265,12.793648455672542,"['BCL2A1', 'BAG3', 'BIK', 'IL1R2', 'CASP4', 'CASP1', 'CYCS', 'TNFRSF1B', 'HSPA1A']",0.17436623171717724,0,0,9
21,Gastric acid production WP2596,0.009724606481313102,23.200542005420054,107.49033499773822,"['CCK', 'VIP']",0.17643214616096628,0,0,2
22,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.011567631962600466,2.2416263736263735,9.996632406852706,"['ADCYAP1', 'EGR1', 'TPH1', 'SST', 'IL1B', 'SSTR1', 'GATA2', 'TAC1', 'ALDOA', 'GAPDH', 'YWHAG', 'YWHAH']",0.19492580341315982,0,0,12
23,Sulfation Biotransformation Reaction WP692,0.011767174484258992,7.740841248303935,34.38823399874282,"['SULT1C2', 'SULT1B1', 'SULT4A1']",0.19492580341315982,0,0,3
24,Myometrial relaxation and contraction pathways WP289,0.016645955616306225,2.121878121878122,8.69033856916088,"['RGS4', 'GNG3', 'PRKCH', 'IL1B', 'CRH', 'SFN', 'CALM3', 'CALM1', 'ACTB', 'YWHAG', 'ACTG1', 'YWHAH']",0.26425454540886134,0,0,12
25,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.018283904364002252,3.1024523160762945,12.415189379228888,"['BEX3', 'SOCS3', 'CDKN1A', 'HSPA5', 'HSPB1', 'YBX3']",0.2679295216417253,0,0,6
26,Proximal tubule transport WP4917,0.018283904364002252,3.1024523160762945,12.415189379228888,"['SLC22A6', 'SLC3A1', 'ATP6V0A4', 'SLC22A8', 'ATP6V1B1', 'ATP6V1F']",0.2679295216417253,0,0,6
27,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.019069196542440037,2.762156912618216,10.937260224573045,"['HSPA8', 'TUBB2A', 'HSPA5', 'CASP1', 'TUBA4A', 'HSPA1B', 'HSPA1A']",0.2690875512099872,0,0,7
28,Folate Metabolism WP176,0.019968122217440955,3.034829996445919,11.877165805263862,"['SERPINA3', 'GPX4', 'RFK', 'IL1B', 'CCL2', 'PLG']",0.2717090916016073,0,0,6
29,Thyroxine (Thyroid Hormone) Production WP1981,0.023002183071970498,11.598915989159892,43.75303828706271,"['TPO', 'CGA']",0.2921277250140253,0,0,2
30,let-7 inhibition of ES cell reprogramming WP3299,0.023002183071970498,11.598915989159892,43.75303828706271,"['EGR1', 'KLF4']",0.2921277250140253,0,0,2
31,Glycolysis and Gluconeogenesis WP534,0.026300206429224152,3.2290249433106575,11.747769095039526,"['LDHA', 'TPI1', 'PGAM1', 'ALDOA', 'GAPDH']",0.32323802095272264,0,0,5
32,White fat cell differentiation WP4149,0.030465299146082776,3.7171739130434784,12.977274809241964,"['EGR2', 'MECOM', 'GATA2', 'KLF4']",0.33156091628830314,0,0,4
33,Blood Clotting Cascade WP272,0.03119937984747547,4.9748013180849,17.249412477571195,"['F8A1', 'VWF', 'PLG']",0.33156091628830314,0,0,3
34,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.031328590515430216,9.27859078590786,32.133839811742476,"['IL1B', 'CASP1']",0.33156091628830314,0,0,2
35,COVID-19 adverse outcome pathway WP4891,0.031328590515430216,9.27859078590786,32.133839811742476,"['IL1B', 'CCL2']",0.33156091628830314,0,0,2
36,Nanomaterial-induced inflammasome activation WP3890,0.031328590515430216,9.27859078590786,32.133839811742476,"['IL1B', 'CASP1']",0.33156091628830314,0,0,2
37,Oncostatin M Signaling Pathway WP2374,0.03731370407807266,2.584014532243415,8.497259481311323,"['SOCS3', 'EGR1', 'PRKCH', 'CDK2', 'CCL2', 'OSMR']",0.38423030415528875,0,0,6
38,VEGFA-VEGFR2 Signaling Pathway WP3888,0.03981165538380418,1.5002689618074234,4.836260365174859,"['FLT1', 'HSPB1', 'GATA2', 'ELK1', 'APOLD1', 'ACTG1', 'CDH5', 'LDHA', 'CCL2', 'DNAJB9', 'SH3BGRL3', 'IER5', 'TMSB10', 'CLIC1', 'EGR1', 'HSP90AA1', 'EGR3', 'DKK1', 'SELE', 'CYCS', 'RPL26', 'ALDOA', 'GAPDH', 'HSPA1A', 'EPHA2']",0.3976919478140535,0,0,25
39,Lung fibrosis WP3624,0.0407086245793913,2.83441181350589,9.073845913169311,"['SERPINA1', 'IL1B', 'HMOX1', 'CCL2', 'TIMP1']",0.3976919478140535,0,0,5
40,Hematopoietic Stem Cell Differentiation WP2849,0.04406464747612499,2.7667638483965016,8.638106390555043,"['TPO', 'IL1B', 'GATA2', 'CD34', 'GATA1']",0.4197157672100906,0,0,5
41,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.047747658277292056,4.096176869662384,12.459854249329513,"['H2AFZ', 'DUSP6', 'HIST1H3E']",0.4437038488694701,0,0,3
42,Fatty Acid Omega Oxidation WP206,0.050844449735743556,6.626790553619822,19.741105099365164,"['CYP2A6', 'ADH1B']",0.461231794031388,0,0,2
43,IL1 and megakaryocytes in obesity WP2865,0.054046362837903775,3.8683853459972863,11.287612005012662,"['IL1B', 'CCL2', 'TIMP1']",0.47887591258700785,0,0,3
44,NRF2 pathway WP2884,0.05642582115369377,1.9218991202198823,5.525130179224889,"['EGR1', 'DNAJB1', 'HSP90AA1', 'CYP2A6', 'SERPINA1', 'SRXN1', 'HMOX1', 'EPHA2', 'HSPA1A']",0.4809043315811803,0,0,9
45,Vitamin D Receptor Pathway WP2877,0.05860787529669919,1.8333513105382375,5.2010090339014425,"['SULT1C2', 'COLEC11', 'IL1RL1', 'CDKN1A', 'CEACAM1', 'COL13A1', 'CASP5', 'CDK2', 'PNOC', 'KLF4']",0.4809043315811803,0,0,10
46,Cardiac Progenitor Differentiation WP2406,0.060364211825982936,2.9028532608695654,8.14935084756247,"['MESP1', 'THY1', 'DKK1', 'NODAL']",0.4809043315811803,0,0,4
47,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.060364211825982936,2.9028532608695654,8.14935084756247,"['HSD3B1', 'CALM3', 'REN', 'CALM1']",0.4809043315811803,0,0,4
48,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.0618485885760573,5.79810298102981,16.136503273996116,"['KLF4', 'ELK1']",0.4809043315811803,0,0,2
49,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.0618485885760573,5.79810298102981,16.136503273996116,"['SOCS3', 'CHI3L1']",0.4809043315811803,0,0,2
50,Vitamin D-sensitive calcium signaling in depression WP4698,0.06556009549910816,2.8147233201581026,7.669524518727379,"['TPH1', 'CALB1', 'GPX4', 'PVALB']",0.48977247814039626,0,0,4
51,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.06556009549910816,2.8147233201581026,7.669524518727379,"['HSP90AA1', 'CASP5', 'IL1B', 'CASP1']",0.48977247814039626,0,0,4
52,Differentiation Pathway WP2848,0.07098099679702188,2.7317774936061383,7.226488712063211,"['TPO', 'FST', 'DKK1', 'NODAL']",0.5096395502452249,0,0,4
53,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.07357001381492748,5.15356820234869,13.448327737272303,"['HSD11B2', 'HSD3B1']",0.5096395502452249,0,0,2
54,Glycolysis in senescence WP5049,0.07357001381492748,5.15356820234869,13.448327737272303,"['LDHA', 'GAPDH']",0.5096395502452249,0,0,2
55,Role of Osx and miRNAs in tooth development WP3971,0.07357001381492748,5.15356820234869,13.448327737272303,"['KLF4', 'DKK1']",0.5096395502452249,0,0,2
56,Microglia Pathogen Phagocytosis Pathway WP3937,0.07662354491787719,2.6535714285714285,6.81662928498934,"['C1QB', 'C1QA', 'FCER1G', 'C1QC']",0.5196755055581432,0,0,4
57,Calcium Regulation in the Cardiac Cell WP536,0.07916387690137237,1.723896499238965,4.372206954835727,"['RGS4', 'GNG3', 'PRKCH', 'PLN', 'GJA4', 'SFN', 'CALM3', 'CALM1', 'YWHAG', 'YWHAH']",0.5196755055581432,0,0,10
58,Vitamin A and carotenoid metabolism WP716,0.08248390826711727,2.579710144927536,6.436769071933318,"['CYP26B1', 'RBP4', 'RBP2', 'NPC1L1']",0.5196755055581432,0,0,4
59,Fas ligand pathway and stress induction of heat shock proteins WP314,0.08248390826711727,2.579710144927536,6.436769071933318,"['HSPB1', 'CYCS', 'ACTB', 'ACTG1']",0.5196755055581432,0,0,4
60,Nuclear Receptors Meta-Pathway WP2882,0.08319573728282884,1.5038317590447337,3.7393666461519466,"['SRGN', 'EGR1', 'HSP90AA1', 'SERPINA1', 'GADD45B', 'SRXN1', 'DNAJB1', 'CYP2A6', 'IL1B', 'ENC1', 'PDK4', 'HMOX1', 'CCL2', 'EPHA2', 'HSPA1A', 'FKBP5']",0.5196755055581432,0,0,16
61,ACE Inhibitor Pathway WP554,0.08593059540725204,4.637940379403794,11.382504419113543,"['ATP6AP2', 'REN']",0.5196755055581432,0,0,2
62,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.08593059540725204,4.637940379403794,11.382504419113543,"['SST', 'DKK1']",0.5196755055581432,0,0,2
63,Transcriptional cascade regulating adipogenesis WP4211,0.08593059540725204,4.637940379403794,11.382504419113543,"['EGR2', 'GATA2']",0.5196755055581432,0,0,2
64,Vitamin B12 metabolism WP1533,0.08855782625001514,2.5098413631022325,6.08410528470531,"['SERPINA3', 'IL1B', 'CCL2', 'PLG']",0.5271958093946214,0,0,4
65,NO/cGMP/PKG mediated Neuroprotection WP4008,0.09484064083890129,2.443649885583524,5.756157230728945,"['IL1B', 'NEFL', 'CYCS', 'CALM1']",0.5559120639941751,0,0,4
66,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.09929676544096301,2.900271370420624,6.698589386592313,"['BCL2A1', 'IL1B', 'SELE']",0.5732131459546501,0,0,3
67,Allograft Rejection WP2328,0.10781543193931915,2.073372206025267,4.618093398811094,"['C1QB', 'C1QA', 'HLA-DRB5', 'IL1B', 'C1QC']",0.6130996950579194,0,0,5
68,Cytokines and Inflammatory Response WP530,0.11228254383886538,3.86449864498645,8.450641677002857,"['IL1B', 'CXCL1']",0.6268223445115623,0,0,2
69,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.1135190072737475,2.03687790905836,4.431808383261731,"['CDKN1A', 'NEFL', 'NEFM', 'ELK1', 'PFN2']",0.6268223445115623,0,0,5
70,"COVID-19, thrombosis and anticoagulation WP4927",0.1192015618408446,11.584573748308525,24.639686589390543,['PLG'],0.6316355915715594,0,0,1
71,Nicotine Metabolism WP1600,0.1192015618408446,11.584573748308525,24.639686589390543,['CYP2A6'],0.6316355915715594,0,0,1
72,Glucocorticoid Receptor Pathway WP2880,0.11936420628123956,2.0016420361247946,4.254642078129931,"['SRGN', 'HSP90AA1', 'GADD45B', 'ENC1', 'CCL2']",0.6316355915715594,0,0,5
73,Circadian rhythm related genes WP3594,0.12145252691746074,1.5321373713478392,3.2301007550771508,"['PER2', 'NTRK1', 'EGR1', 'TPH1', 'EGR3', 'SIX3', 'CRH', 'CARTPT', 'RPS27A', 'DRD3', 'HCRTR1']",0.63237281472799,0,0,11
74,Sleep regulation WP3591,0.12610561521264205,2.57756671189507,5.337201155734228,"['CRH', 'DRD3', 'HCRTR1']",0.63237281472799,0,0,3
75,Endothelin Pathways WP2197,0.12610561521264205,2.57756671189507,5.337201155734228,"['ADCY10', 'NPY', 'CALM1']",0.63237281472799,0,0,3
76,ID signaling pathway WP53,0.12614260871214497,3.5670210548259327,7.384954206947074,"['CDK2', 'ELK1']",0.63237281472799,0,0,2
77,Melanoma WP4685,0.1314671187695701,1.9346938775510205,3.925490987139787,"['CDKN1A', 'GADD45B', 'CALM3', 'CALM1', 'ELK1']",0.6505061331325482,0,0,5
78,Prion disease pathway WP3995,0.1355624592039227,2.485365380887769,4.966562285421384,"['PRNP', 'HSPA5', 'ELK1']",0.6621704738037764,0,0,3
79,Glutathione metabolism WP100,0.14037867610107374,3.3120402632597754,6.50289853270307,"['GGT5', 'GPX4']",0.6770161467659379,0,0,2
80,DNA damage response WP707,0.14409788629606204,1.8720649550142638,3.6266811308217948,"['CDKN1A', 'GADD45B', 'CDK2', 'CYCS', 'SFN']",0.6862661834849955,0,0,5
81,Mitochondrial complex I assembly model OXPHOS system WP4324,0.15195744060958796,2.0177221172022684,3.801700798737857,"['NDUFB10', 'NDUFB11', 'NDUFS5', 'NDUFA1']",0.7147627762006544,0,0,4
82,miRNA regulation of DNA damage response WP1530,0.15722795226287728,1.8133503401360545,3.354804394150921,"['CDKN1A', 'GADD45B', 'CDK2', 'CYCS', 'SFN']",0.725841844266025,0,0,5
83,Pathogenic Escherichia coli infection WP2272,0.15986006381858542,1.9746762257169288,3.620482857901667,"['TUBB2A', 'ACTB', 'TUBA4A', 'ACTG1']",0.725841844266025,0,0,4
84,IL-18 signaling pathway WP4754,0.16002812314526538,1.3932073605943243,2.552921122120729,"['SLC12A3', 'NRN1', 'HSPB1', 'GATA1', 'SOCS3', 'ARL4D', 'IL1B', 'HMOX1', 'CYCS', 'CCL2', 'TIMP1', 'IL18R1', 'TGM2']",0.725841844266025,0,0,13
85,Amyotrophic lateral sclerosis (ALS) WP2447,0.16527723288942645,2.2444522256751434,4.0403080647115015,"['CASP1', 'NEFL', 'NEFM']",0.7408308909514292,0,0,3
86,Apoptosis Modulation by HSP70 WP384,0.16976341264714565,2.8976964769647697,5.138628603048843,"['CYCS', 'HSPA1A']",0.7519425065506449,0,0,2
87,Metapathway biotransformation Phase I and II WP702,0.17170340700762757,1.5230672758219117,2.683624235199662,"['CYP39A1', 'SULT1B1', 'SULT1C2', 'CYP26B1', 'CYP2A6', 'GPX4', 'GLYAT', 'SULT4A1']",0.7519425065506449,0,0,8
88,Adipogenesis WP236,0.1827249120888691,1.5478854024556616,2.6310545412725657,"['SOCS3', 'EGR2', 'CDKN1A', 'CYP26B1', 'GADD45B', 'MIF', 'GATA2']",0.7636906649854076,0,0,7
89,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.18481386634579974,2.727084329666826,4.604425785382671,"['HTR2B', 'ELK1']",0.7636906649854076,0,0,2
90,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.18481386634579974,2.727084329666826,4.604425785382671,"['EGR1', 'ELK1']",0.7636906649854076,0,0,2
91,Tryptophan metabolism WP465,0.18605261675663903,2.1081781176760823,3.5453774460788767,"['TPH1', 'DHCR24', 'ACMSD']",0.7636906649854076,0,0,3
92,Small cell lung cancer WP4658,0.18808023038855676,1.60077045945692,2.674705990102832,"['CDKN1A', 'LAMB3', 'GADD45B', 'CDK2', 'CKS2', 'CYCS']",0.7636906649854076,0,0,6
93,Steroid Biosynthesis WP496,0.19067631327494697,5.7916102841677946,9.597729051650765,['HSD3B1'],0.7636906649854076,0,0,1
94,miR-517 relationship with ARCN1 and USP1 WP3596,0.19067631327494697,5.7916102841677946,9.597729051650765,['CDKN1A'],0.7636906649854076,0,0,1
95,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.19067631327494697,5.7916102841677946,9.597729051650765,['REN'],0.7636906649854076,0,0,1
96,Cytosolic DNA-sensing pathway WP4655,0.1928687635472956,1.8193734015345269,2.994225229960094,"['IL1B', 'CASP1', 'IRF7', 'POLR2K']",0.7636906649854076,0,0,4
97,Pathways Regulating Hippo Signaling WP4540,0.19443043176793842,1.5824869952935348,2.591608658946048,"['NTRK1', 'CDH5', 'PRKCH', 'FLT1', 'TEAD2', 'EPHA2']",0.7636906649854076,0,0,6
98,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.20004344942889904,2.5754290876242094,4.14443377055942,"['FCGR2A', 'IL1B']",0.7730080200169741,0,0,2
99,Senescence and Autophagy in Cancer WP615,0.2008603516579539,1.5646143954933718,2.5114335688097555,"['CDKN1A', 'IL1B', 'IRF7', 'CXCL1', 'GABARAP', 'CD44']",0.7730080200169741,0,0,6
100,Apoptosis WP254,0.2066612725615801,1.633898629874485,2.5761257995514115,"['CASP4', 'CASP1', 'IRF7', 'CYCS', 'TNFRSF1B']",0.7825924235703563,0,0,5
101,Ferroptosis WP4313,0.2074588839385984,1.9874781934483428,3.1259496430937115,"['PRNP', 'GPX4', 'HMOX1']",0.7825924235703563,0,0,3
102,Matrix Metalloproteinases WP129,0.2154115673098303,2.4397375552702893,3.745496840163463,"['MMP19', 'TIMP1']",0.7909671239612399,0,0,2
103,Cell cycle WP179,0.21766863769256659,1.463699716087165,2.231822077634567,"['CDKN1A', 'PTTG1', 'GADD45B', 'CDK2', 'SFN', 'YWHAG', 'YWHAH']",0.7909671239612399,0,0,7
104,Ebola Virus Pathway on Host WP4217,0.21766863769256659,1.463699716087165,2.231822077634567,"['SOCS3', 'HLA-DRB5', 'SCIN', 'ICAM2', 'IRF7', 'ACTB', 'ACTG1']",0.7909671239612399,0,0,7
105,Alzheimer's disease WP2059,0.22164046330722706,1.5889479079302955,2.3940658181545422,"['IL1B', 'CYCS', 'CALM3', 'CALM1', 'GAPDH']",0.7909671239612399,0,0,5
106,Effects of nitric oxide WP1995,0.2242111532488554,4.633017591339648,6.9271351182004715,['XDH'],0.7909671239612399,0,0,1
107,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.2242111532488554,4.633017591339648,6.9271351182004715,['CDKN1A'],0.7909671239612399,0,0,1
108,miRNA Biogenesis WP2338,0.2242111532488554,4.633017591339648,6.9271351182004715,['RAN'],0.7909671239612399,0,0,1
109,Common Pathways Underlying Drug Addiction WP2636,0.22937896047780595,1.8798269096776559,2.7678191579029816,"['CALM1', 'ACTB', 'ACTG1']",0.7924823095981541,0,0,3
110,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.23088067287505276,2.3176151761517616,3.397286101177273,"['SRXN1', 'HMOX1']",0.7924823095981541,0,0,2
111,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.23088067287505276,2.3176151761517616,3.397286101177273,"['BCL2A1', 'BCL2L14']",0.7924823095981541,0,0,2
112,Aryl Hydrocarbon Receptor Netpath WP2586,0.24049641931266702,1.8302506605727344,2.6081988467184964,"['CDKN1A', 'HSP90AA1', 'CDK2']",0.8005942230119875,0,0,3
113,IL-6 signaling pathway WP364,0.24049641931266702,1.8302506605727344,2.6081988467184964,"['SOCS3', 'TIMP1', 'VIP']",0.8005942230119875,0,0,3
114,22q11.2 copy number variation syndrome WP4657,0.2409509135273189,1.46528036713036,2.0853314031192447,"['CLDN5', 'CYP26B1', 'FOXC1', 'VWF', 'SERPIND1', 'RAN']",0.8005942230119875,0,0,6
115,Constitutive Androstane Receptor Pathway WP2875,0.24641608418650926,2.2071234998064266,3.0915924267477757,"['HSP90AA1', 'CYP2A6']",0.8005942230119875,0,0,2
116,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.24641608418650926,2.2071234998064266,3.0915924267477757,"['SCO2', 'IL1B']",0.8005942230119875,0,0,2
117,RAS and bradykinin pathways in COVID-19 WP4969,0.24641608418650926,2.2071234998064266,3.0915924267477757,"['IL1B', 'REN']",0.8005942230119875,0,0,2
118,Metabolic reprogramming in colon cancer WP4290,0.2517007104949916,1.7832167832167831,2.459973505491292,"['LDHA', 'PGAM1', 'GAPDH']",0.8005942230119875,0,0,3
119,Oxidation by Cytochrome P450 WP43,0.2517007104949916,1.7832167832167831,2.459973505491292,"['CYP39A1', 'CYP26B1', 'CYP2A6']",0.8005942230119875,0,0,3
120,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.2563582551376968,3.8606224627875507,5.254999685162283,['DHCR24'],0.8005942230119875,0,0,1
121,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.2563582551376968,3.8606224627875507,5.254999685162283,['VIP'],0.8005942230119875,0,0,1
122,Molybdenum cofactor (Moco) biosynthesis WP4507,0.2563582551376968,3.8606224627875507,5.254999685162283,['XDH'],0.8005942230119875,0,0,1
123,Unfolded protein response WP4925,0.26198581219057915,2.1066765213106677,2.821819316267396,"['HSPA5', 'IL1B']",0.8015591214319792,0,0,2
124,Pregnane X receptor pathway WP2876,0.26198581219057915,2.1066765213106677,2.821819316267396,"['HSP90AA1', 'CYP2A6']",0.8015591214319792,0,0,2
125,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.2629787143805706,1.7385345997286297,2.32212969111446,"['ACTB', 'TEAD2', 'ACTG1']",0.8015591214319792,0,0,3
126,Pathways in clear cell renal cell carcinoma WP4018,0.2683325754737179,1.4677516576250753,1.9308685707937496,"['LDHA', 'FLT1', 'TPI1', 'ALDOA', 'GAPDH']",0.811386597265766,0,0,5
127,Photodynamic therapy-induced unfolded protein response WP3613,0.2775603975513218,2.014964062684105,2.5826131306392384,"['HSPA5', 'DNAJB9']",0.8285218478313892,0,0,2
128,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2857053553407973,1.6555534018220586,2.074067741463655,"['CDKN1A', 'HSP90AA1', 'ELK1']",0.8285218478313892,0,0,3
129,Dual hijack model of Vif in HIV infection WP3300,0.2871749712167074,3.3089116566789096,4.128408607086457,['ELOB'],0.8285218478313892,0,0,1
130,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.2871749712167074,3.3089116566789096,4.128408607086457,['ELOB'],0.8285218478313892,0,0,1
131,Mitochondrial CII Assembly WP4920,0.2871749712167074,3.3089116566789096,4.128408607086457,['SDHAF1'],0.8285218478313892,0,0,1
132,NAD Biosynthesis II (from tryptophan) WP2485,0.2871749712167074,3.3089116566789096,4.128408607086457,['KMO'],0.8285218478313892,0,0,1
133,Gastrin signaling pathway WP4659,0.2903567358497187,1.3641609232248757,1.6869827690281227,"['EGR1', 'CDKN1A', 'PRKCH', 'KLF4', 'ELK1', 'CD44']",0.8285218478313892,0,0,6
134,"GPCRs, Other WP117",0.29199103037560986,1.495617110799439,1.8411528149027618,"['GNRHR', 'OR10A2', 'DRD3', 'GPR18']",0.8285218478313892,0,0,4
135,Mesodermal commitment pathway WP2857,0.29357073348356305,1.319968056433634,1.6178012516173996,"['FOXC1', 'ZIC3', 'KLF4', 'DKK1', 'NODAL', 'TEAD2', 'TBX3']",0.8285218478313892,0,0,7
136,TNF-alpha signaling pathway WP231,0.3005674482769946,1.3966887960003278,1.6789359930110659,"['HSP90AA1', 'RFK', 'CCL2', 'TNFRSF1B', 'SELE']",0.8379785089018817,0,0,5
137,Exercise-induced Circadian Regulation WP410,0.30857943574356134,1.5801159491797212,1.8578623763328506,"['PER2', 'HSPA8', 'CLDN5']",0.8379785089018817,0,0,3
138,Netrin-UNC5B signaling pathway WP4747,0.30857943574356134,1.5801159491797212,1.8578623763328506,"['CDH5', 'CCL2', 'SELE']",0.8379785089018817,0,0,3
139,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.3086180347657634,1.853550135501355,2.1791278853154847,"['GGT5', 'TRPA1']",0.8379785089018817,0,0,2
140,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.3086180347657634,1.853550135501355,2.1791278853154847,"['IL1B', 'CXCL1']",0.8379785089018817,0,0,2
141,Hippo-Merlin Signaling Dysregulation WP4541,0.3121533782078371,1.3249513429349942,1.5425886655650674,"['NTRK1', 'CDH5', 'FLT1', 'TEAD2', 'CD44', 'EPHA2']",0.8379785089018817,0,0,6
142,Tgif disruption of Shh signaling WP3674,0.31671628682905767,2.895128552097429,3.3286708683683406,['NODAL'],0.8379785089018817,0,0,1
143,Estrogen Receptor Pathway WP2881,0.31671628682905767,2.895128552097429,3.3286708683683406,['PDK4'],0.8379785089018817,0,0,1
144,Macrophage markers WP4146,0.31671628682905767,2.895128552097429,3.3286708683683406,['CD163'],0.8379785089018817,0,0,1
145,Ovarian infertility WP34,0.32405347027126097,1.7821555138628309,2.008216140066579,"['EGR1', 'GJA4']",0.8514784287817272,0,0,2
146,Hepatitis B infection WP4666,0.3268328048847333,1.2680337653478855,1.4180504513218644,"['EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'IRF7', 'CYCS', 'ELK1']",0.8528993058978315,0,0,7
147,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.3315107840644001,1.511238275028022,1.6685505307354798,"['IRF7', 'CCL2', 'CXCL1']",0.8536253486354695,0,0,3
148,Oxidative Stress WP408,0.3393982623066013,1.7160493827160495,1.8543304371228462,"['HMOX1', 'XDH']",0.8536253486354695,0,0,2
149,Copper homeostasis WP3286,0.3429716338805525,1.4789976615953115,1.5826865423534753,"['PRNP', 'MT1A', 'SCO2']",0.8536253486354695,0,0,3
150,Peptide GPCRs WP24,0.3429716338805525,1.4789976615953115,1.5826865423534753,"['GNRHR', 'SSTR1', 'HCRTR1']",0.8536253486354695,0,0,3
151,Tamoxifen metabolism WP691,0.34503491782116086,2.573297248534055,2.738270449914169,['CYP2A6'],0.8536253486354695,0,0,1
152,Valproic acid pathway WP3871,0.34503491782116086,2.573297248534055,2.738270449914169,['CYP2A6'],0.8536253486354695,0,0,1
153,Dopamine metabolism WP2436,0.34503491782116086,2.573297248534055,2.738270449914169,['TYR'],0.8536253486354695,0,0,1
154,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.34503491782116086,2.573297248534055,2.738270449914169,['HMOX1'],0.8536253486354695,0,0,1
155,Type II interferon signaling (IFNG) WP619,0.3546334487500142,1.6546651180797523,1.7153426173428064,"['SOCS3', 'IL1B']",0.8606072864570409,0,0,2
156,GABA receptor Signaling WP4159,0.3546334487500142,1.6546651180797523,1.7153426173428064,"['SLC32A1', 'GABRE']",0.8606072864570409,0,0,2
157,Monoamine GPCRs WP58,0.3546334487500142,1.6546651180797523,1.7153426173428064,"['HTR2B', 'DRD3']",0.8606072864570409,0,0,2
158,Aryl Hydrocarbon Receptor Pathway WP2873,0.3697417897015807,1.597514251004579,1.5894474153048557,"['HSP90AA1', 'IL1B']",0.8606939051159493,0,0,2
159,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.3697417897015807,1.597514251004579,1.5894474153048557,"['CCL2', 'PLG']",0.8606939051159493,0,0,2
160,Serotonin Transporter Activity WP1455,0.3721814040137389,2.315832205683356,2.288908105104481,['IL1B'],0.8606939051159493,0,0,1
161,Biogenic Amine Synthesis WP550,0.3721814040137389,2.315832205683356,2.288908105104481,['TPH1'],0.8606939051159493,0,0,1
162,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.3721814040137389,2.315832205683356,2.288908105104481,['TPO'],0.8606939051159493,0,0,1
163,Leptin signaling pathway WP2034,0.3771909229282979,1.3053429271279853,1.2727143049320058,"['SOCS3', 'CISH', 'IL1B', 'ELK1']",0.8606939051159493,0,0,4
164,Prolactin Signaling Pathway WP2037,0.3771909229282979,1.3053429271279853,1.2727143049320058,"['SOCS3', 'CISH', 'ELK1', 'YWHAG']",0.8606939051159493,0,0,4
165,MAPK Signaling Pathway WP382,0.3828144110831292,1.1384234763864394,1.093119884094154,"['DUSP4', 'NTRK1', 'HSPA8', 'DUSP2', 'IL1R2', 'IL1B', 'HSPB1', 'ELK1', 'DUSP6', 'HSPA1B', 'HSPA1A']",0.8606939051159493,0,0,11
166,Serotonin and anxiety-related events WP3944,0.39820419896044,2.1051789888055112,1.9384284822411826,['CRH'],0.8606939051159493,0,0,1
167,EDA signaling in hair follicle development WP3930,0.39820419896044,2.1051789888055112,1.9384284822411826,['DKK1'],0.8606939051159493,0,0,1
168,Iron metabolism in placenta WP2007,0.39820419896044,2.1051789888055112,1.9384284822411826,['HEPHL1'],0.8606939051159493,0,0,1
169,LTF danger signal response pathway WP4478,0.39820419896044,2.1051789888055112,1.9384284822411826,['IL1B'],0.8606939051159493,0,0,1
170,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.39820419896044,2.1051789888055112,1.9384284822411826,['TIMP1'],0.8606939051159493,0,0,1
171,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.39820419896044,2.1051789888055112,1.9384284822411826,['HLA-DRB5'],0.8606939051159493,0,0,1
172,Purine metabolism WP4792,0.39820419896044,2.1051789888055112,1.9384284822411826,['XDH'],0.8606939051159493,0,0,1
173,RalA downstream regulated genes WP2290,0.39820419896044,2.1051789888055112,1.9384284822411826,['YBX3'],0.8606939051159493,0,0,1
174,Type 2 papillary renal cell carcinoma WP4241,0.3995169342111261,1.4942739749978144,1.3709950663051977,"['CDKN1A', 'ELOB']",0.8606939051159493,0,0,2
175,Zinc homeostasis WP3529,0.3995169342111261,1.4942739749978144,1.3709950663051977,"['MT1A', 'SLC30A2']",0.8606939051159493,0,0,2
176,Melatonin metabolism and effects WP3298,0.3995169342111261,1.4942739749978144,1.3709950663051977,"['PER2', 'CALM1']",0.8606939051159493,0,0,2
177,Prader-Willi and Angelman Syndrome WP3998,0.39984992442394496,1.3363949483352469,1.2250277999708121,"['PCSK1', 'CGA', 'TYR']",0.8606939051159493,0,0,3
178,Ras signaling WP4223,0.4076683025113033,1.1443027727180732,1.0267845020341175,"['NTRK1', 'GNG3', 'FLT1', 'CALM3', 'CALM1', 'ELK1', 'PLA1A', 'EPHA2']",0.8665707240637952,0,0,8
179,CAMKK2  Pathway WP4874,0.41415691112493835,1.4474932249322494,1.275980280444045,"['HMOX1', 'CALM1']",0.8665707240637952,0,0,2
180,p38 MAPK Signaling Pathway WP400,0.41415691112493835,1.4474932249322494,1.275980280444045,"['HSPB1', 'ELK1']",0.8665707240637952,0,0,2
181,Parkinson's disease pathway WP2371,0.41415691112493835,1.4474932249322494,1.275980280444045,"['PINK1', 'CYCS']",0.8665707240637952,0,0,2
182,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.42314975583301745,1.9296346414073071,1.6595420016521951,['CCK'],0.8665707240637952,0,0,1
183,Farnesoid X receptor pathway WP2879,0.42314975583301745,1.9296346414073071,1.6595420016521951,['FKBP5'],0.8665707240637952,0,0,1
184,Amino Acid metabolism WP3925,0.4243232624215865,1.2191075514874141,1.045091777350315,"['TPH1', 'TPO', 'LDHA', 'PDK4']",0.8665707240637952,0,0,4
185,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.42861619906186504,1.4035476718403548,1.1890763260851318,"['IFITM3', 'IFITM2']",0.8665707240637952,0,0,2
186,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.42861619906186504,1.4035476718403548,1.1890763260851318,"['LDHA', 'BCL2A1']",0.8665707240637952,0,0,2
187,Corticotropin-releasing hormone signaling pathway WP2355,0.4429441930348026,1.1877090301003344,0.9671651123192501,"['HSP90AA1', 'HSD3B1', 'CRH', 'ELK1']",0.8665707240637952,0,0,4
188,Cells and molecules involved in local acute inflammatory response  WP4493,0.4470626100145332,1.7810971166857499,1.4338840371726869,['SELP'],0.8665707240637952,0,0,1
189,Cysteine and methionine catabolism WP4504,0.4470626100145332,1.7810971166857499,1.4338840371726869,['SQOR'],0.8665707240637952,0,0,1
190,Phytochemical activity on NRF2 transcriptional activation WP3,0.4470626100145332,1.7810971166857499,1.4338840371726869,['HMOX1'],0.8665707240637952,0,0,1
191,Riboflavin and CoQ disorders WP5037,0.4470626100145332,1.7810971166857499,1.4338840371726869,['RFK'],0.8665707240637952,0,0,1
192,Selective expression of chemokine receptors during T-cell polarization WP4494,0.46998545806578707,1.6537792383529866,1.2486918435601144,['IL18R1'],0.8665707240637952,0,0,1
193,Airway smooth muscle cell contraction WP4962,0.46998545806578707,1.6537792383529866,1.2486918435601144,['CALM1'],0.8665707240637952,0,0,1
194,Cell Differentiation - Index expanded WP2023,0.46998545806578707,1.6537792383529866,1.2486918435601144,['KLF4'],0.8665707240637952,0,0,1
195,Tryptophan catabolism leading to NAD+ production WP4210,0.46998545806578707,1.6537792383529866,1.2486918435601144,['KMO'],0.8665707240637952,0,0,1
196,Development and heterogeneity of the ILC family WP3893,0.46998545806578707,1.6537792383529866,1.2486918435601144,['IL1B'],0.8665707240637952,0,0,1
197,ERK Pathway in Huntington's Disease WP3853,0.46998545806578707,1.6537792383529866,1.2486918435601144,['ELK1'],0.8665707240637952,0,0,1
198,Galanin receptor pathway WP4970,0.46998545806578707,1.6537792383529866,1.2486918435601144,['CDKN1A'],0.8665707240637952,0,0,1
199,Leptin Insulin Overlap WP3935,0.46998545806578707,1.6537792383529866,1.2486918435601144,['SOCS3'],0.8665707240637952,0,0,1
200,Major receptors targeted by epinephrine and norepinephrine WP4589,0.46998545806578707,1.6537792383529866,1.2486918435601144,['ADCY10'],0.8665707240637952,0,0,1
201,miRNAs involved in DNA damage response WP1545,0.46998545806578707,1.6537792383529866,1.2486918435601144,['CDKN1A'],0.8665707240637952,0,0,1
202,Overview of nanoparticle effects WP3287,0.46998545806578707,1.6537792383529866,1.2486918435601144,['HMOX1'],0.8665707240637952,0,0,1
203,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.46998545806578707,1.6537792383529866,1.2486918435601144,['PTTG1'],0.8665707240637952,0,0,1
204,Androgen receptor signaling pathway WP138,0.47051855545737653,1.1435185185185186,0.8621213476816368,"['CDKN1A', 'FKBP4', 'ETV5', 'RAN']",0.8665707240637952,0,0,4
205,G13 Signaling Pathway WP524,0.4708140154362352,1.2863595302619693,0.9690045164569899,"['MYBPH', 'CALM1']",0.8665707240637952,0,0,2
206,IL-2 signaling pathway WP49,0.4708140154362352,1.2863595302619693,0.9690045164569899,"['SOCS3', 'CISH']",0.8665707240637952,0,0,2
207,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.4708140154362352,1.2863595302619693,0.9690045164569899,"['PRKCH', 'HSD3B1']",0.8665707240637952,0,0,2
208,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4844600733592207,1.2515198124954223,0.9070017626232012,"['TNFRSF12A', 'CCL2']",0.8717975254802425,0,0,2
209,Hedgehog Signaling Pathway WP4249,0.4844600733592207,1.2515198124954223,0.9070017626232012,"['EVC2', 'EVC']",0.8717975254802425,0,0,2
210,Endometrial cancer WP4155,0.48749231888341177,1.1576662143826324,0.8317608839451671,"['CDKN1A', 'GADD45B', 'ELK1']",0.8717975254802425,0,0,3
211,Cytoplasmic Ribosomal Proteins WP477,0.4886187741307093,1.1158328968046098,0.7991290546153678,"['RPL26', 'RPL15', 'FAU', 'RPS27A']",0.8717975254802425,0,0,4
212,Serotonin and anxiety WP3947,0.4919592335387195,1.5434370771312584,1.0948516369153425,['CRH'],0.8717975254802425,0,0,1
213,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4919592335387195,1.5434370771312584,1.0948516369153425,['SYTL4'],0.8717975254802425,0,0,1
214,Mammalian disorder of sexual development WP4842,0.4919592335387195,1.5434370771312584,1.0948516369153425,['FST'],0.8717975254802425,0,0,1
215,MAPK pathway in congenital thyroid cancer WP4928,0.4919592335387195,1.5434370771312584,1.0948516369153425,['ELK1'],0.8717975254802425,0,0,1
216,ATM Signaling Pathway WP2516,0.4978853886855103,1.2185137640850092,0.8497736742225334,"['CDKN1A', 'CDK2']",0.8741674335906886,0,0,2
217,Glycogen Synthesis and Degradation WP500,0.4978853886855103,1.2185137640850092,0.8497736742225334,"['CALM3', 'CALM1']",0.8741674335906886,0,0,2
218,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5084462547700096,1.1201908346828906,0.7576923340476699,"['EGR1', 'CDK2', 'CGA']",0.8844426765229546,0,0,3
219,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5130231798204015,1.4468876860622464,0.9657023975769673,['HSPB1'],0.8844426765229546,0,0,1
220,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.5130231798204015,1.4468876860622464,0.9657023975769673,['CDKN1A'],0.8844426765229546,0,0,1
221,miR-509-3p alteration of YAP1/ECM axis WP3967,0.5130231798204015,1.4468876860622464,0.9657023975769673,['TEAD2'],0.8844426765229546,0,0,1
222,Eukaryotic Transcription Initiation WP405,0.5240540146688304,1.1574525745257453,0.7479001557462854,"['POLR2I', 'POLR2K']",0.8910301947278693,0,0,2
223,Hepatitis C and Hepatocellular Carcinoma WP3646,0.5240540146688304,1.1574525745257453,0.7479001557462854,"['CDKN1A', 'CD44']",0.8910301947278693,0,0,2
224,BMP Signaling Pathway in Eyelid Development WP3927,0.5332149196796698,1.3616970468837062,0.8562769203533146,['FOXC1'],0.8910301947278693,0,0,1
225,TP53 network WP1742,0.5332149196796698,1.3616970468837062,0.8562769203533146,['CDKN1A'],0.8910301947278693,0,0,1
226,Transcription co-factors SKI and SKIL protein partners WP4533,0.5332149196796698,1.3616970468837062,0.8562769203533146,['TEAD2'],0.8910301947278693,0,0,1
227,Nanomaterial induced apoptosis WP2507,0.5332149196796698,1.3616970468837062,0.8562769203533146,['CYCS'],0.8910301947278693,0,0,1
228,Nicotine Activity on Dopaminergic Neurons WP1602,0.5332149196796698,1.3616970468837062,0.8562769203533146,['DRD3'],0.8910301947278693,0,0,1
229,Integrated Cancer Pathway WP1971,0.5367893879597464,1.1291559257055985,0.7025037523654527,"['CDKN1A', 'CDK2']",0.8930862742911064,0,0,2
230,Regulation of Microtubule Cytoskeleton WP2038,0.5492880322051503,1.1022067363530779,0.6603676859345894,"['PARD6A', 'RHO']",0.8996981577992879,0,0,2
231,Ebstein-Barr virus LMP1 signaling WP262,0.5525705221129484,1.2859720342805594,0.7628054479628505,['HSP90AA1'],0.8996981577992879,0,0,1
232,GDNF/RET signaling axis WP4830,0.5525705221129484,1.2859720342805594,0.7628054479628505,['FOXC1'],0.8996981577992879,0,0,1
233,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.5525705221129484,1.2859720342805594,0.7628054479628505,['LDHA'],0.8996981577992879,0,0,1
234,Nucleotide metabolism WP404,0.5525705221129484,1.2859720342805594,0.7628054479628505,['OAZ1'],0.8996981577992879,0,0,1
235,Regulatory circuits of the STAT3 signaling pathway WP4538,0.558770426853816,1.0362907308774985,0.6031383825061154,"['SOCS3', 'DUSP2', 'OSMR']",0.9059214154523569,0,0,3
236,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5615476839332013,1.0765109976681162,0.6212099141271313,"['ADCY10', 'BANF1']",0.906566388044702,0,0,2
237,Non-small cell lung cancer WP4255,0.5684567326926756,1.0209913001835742,0.576686594217514,"['CDKN1A', 'GADD45B', 'CYCS']",0.9138481652148076,0,0,3
238,Imatinib and Chronic Myeloid Leukemia WP3640,0.5711245665164268,1.2182180756356384,0.6823823432215779,['FLT1'],0.914279243036801,0,0,1
239,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5780109570557422,1.0061353312488939,0.5515256118769157,"['CDKN1A', 'GADD45B', 'CYCS']",0.9174889284201794,0,0,3
240,7q11.23 copy number variation syndrome WP4932,0.5829481785837455,0.9846207215541165,0.5313574490652456,"['CLDN5', 'ATP5MC3', 'GAPDH', 'ATP5MC1']",0.9174889284201794,0,0,4
241,Globo Sphingolipid Metabolism WP1424,0.5889102040249138,1.1572395128552098,0.612736984781168,['A4GALT'],0.9174889284201794,0,0,1
242,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5889102040249138,1.1572395128552098,0.612736984781168,['CCL2'],0.9174889284201794,0,0,1
243,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.5889102040249138,1.1572395128552098,0.612736984781168,['LDHA'],0.9174889284201794,0,0,1
244,Purine metabolism and related disorders WP4224,0.5889102040249138,1.1572395128552098,0.612736984781168,['XDH'],0.9174889284201794,0,0,1
245,Endoderm differentiation WP2853,0.5950727368752561,0.9639455782312926,0.5003568064363437,"['DUSP4', 'DUSP2', 'ZIC3', 'DKK1', 'NODAL']",0.9174889284201794,0,0,5
246,Acute viral myocarditis WP4298,0.5967153444546763,0.9776788273740135,0.504790331021482,"['CASP1', 'CYCS', 'ACTB']",0.9174889284201794,0,0,3
247,Hippo-Yap signaling pathway WP4537,0.6059592165934075,1.1020684322443457,0.5520730197962608,['TEAD2'],0.9174889284201794,0,0,1
248,Inflammatory Response Pathway WP453,0.6059592165934075,1.1020684322443457,0.5520730197962608,['TNFRSF1B'],0.9174889284201794,0,0,1
249,NAD+ biosynthetic pathways WP3645,0.6059592165934075,1.1020684322443457,0.5520730197962608,['ACMSD'],0.9174889284201794,0,0,1
250,NRF2-ARE regulation WP4357,0.6059592165934075,1.1020684322443457,0.5520730197962608,['HMOX1'],0.9174889284201794,0,0,1
251,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6081709158108758,0.9846623998154875,0.4896719467706527,"['IRF7', 'ELK1']",0.9174889284201794,0,0,2
252,Synaptic Vesicle Pathway WP2267,0.6081709158108758,0.9846623998154875,0.4896719467706527,"['RAB3A', 'SLC32A1']",0.9174889284201794,0,0,2
253,IL-4 signaling pathway WP395,0.6192208773504038,0.9640921409214093,0.4620828464822022,"['SOCS3', 'ELK1']",0.9174889284201794,0,0,2
254,Estrogen signaling pathway WP712,0.6223020732124175,1.0519129044162874,0.4989534859679589,['ELK1'],0.9174889284201794,0,0,1
255,Angiogenesis WP1539,0.6379679843218133,1.0061187268341472,0.452217345094627,['FLT1'],0.9174889284201794,0,0,1
256,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.6379679843218133,1.0061187268341472,0.452217345094627,['CALM1'],0.9174889284201794,0,0,1
257,TLR4 Signaling and Tolerance WP3851,0.6379679843218133,1.0061187268341472,0.452217345094627,['IRF7'],0.9174889284201794,0,0,1
258,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.6379679843218133,1.0061187268341472,0.452217345094627,['CGA'],0.9174889284201794,0,0,1
259,Gastric Cancer Network 1 WP2361,0.6379679843218133,1.0061187268341472,0.452217345094627,['GATD3A'],0.9174889284201794,0,0,1
260,Physiological and pathological hypertrophy of the heart WP1528,0.6379679843218133,1.0061187268341472,0.452217345094627,['CALM1'],0.9174889284201794,0,0,1
261,"Relationship between inflammation, COX-2 and EGFR WP4483",0.6379679843218133,1.0061187268341472,0.452217345094627,['PLA1A'],0.9174889284201794,0,0,1
262,Phosphodiesterases in neuronal function WP4222,0.6405969922967817,0.925420054200542,0.4121402048092278,"['ADCY10', 'PDE10A']",0.9174889284201794,0,0,2
263,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6509255318796934,0.907221425155428,0.3895246216512582,"['CDKN1A', 'ACTB']",0.9174889284201794,0,0,2
264,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.6529849536066524,0.9641407307171854,0.41091792861141424,['DKK1'],0.9174889284201794,0,0,1
265,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.6529849536066524,0.9641407307171854,0.41091792861141424,['HIST1H3E'],0.9174889284201794,0,0,1
266,EPO Receptor Signaling WP581,0.6529849536066524,0.9641407307171854,0.41091792861141424,['CISH'],0.9174889284201794,0,0,1
267,MTHFR deficiency WP4288,0.6529849536066524,0.9641407307171854,0.41091792861141424,['CYCS'],0.9174889284201794,0,0,1
268,Modulators of TCR signaling and T cell activation WP5072,0.661016502966087,0.88972274338128,0.36832428305385584,"['NDUFB10', 'ELOB']",0.9174889284201794,0,0,2
269,Glioblastoma signaling pathways WP2261,0.6659565632240307,0.8782611682668361,0.35704024252929395,"['CDKN1A', 'PRKCH', 'CDK2']",0.9174889284201794,0,0,3
270,Focal Adhesion WP306,0.666096711166616,0.8939347116594937,0.3632239158926677,"['FGR', 'FLT1', 'VWF', 'LAMB3', 'ELK1', 'ACTB', 'ACTG1']",0.9174889284201794,0,0,7
271,7-oxo-C and 7beta-HC pathways WP5064,0.6673798277690155,0.9255209742895805,0.3742769227406037,['HSD11B2'],0.9174889284201794,0,0,1
272,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.6673798277690155,0.9255209742895805,0.3742769227406037,['CDKN1A'],0.9174889284201794,0,0,1
273,Purinergic signaling WP4900,0.6673798277690155,0.9255209742895805,0.3742769227406037,['GNAT3'],0.9174889284201794,0,0,1
274,IL-1 signaling pathway WP195,0.6708718362671426,0.8728843892212507,0.34843551527452993,"['IL1B', 'CCL2']",0.9174889284201794,0,0,2
275,Striated Muscle Contraction Pathway WP383,0.6811783443845498,0.8898719683564068,0.3416495424390154,['ACTG1'],0.9174889284201794,0,0,1
276,Intraflagellar transport proteins binding to dynein WP4532,0.6811783443845498,0.8898719683564068,0.3416495424390154,['DYNLL1'],0.9174889284201794,0,0,1
277,Monoamine Transport WP727,0.6811783443845498,0.8898719683564068,0.3416495424390154,['IL1B'],0.9174889284201794,0,0,1
278,Retinoblastoma gene in cancer WP2446,0.6818467098459783,0.8564751997587818,0.327987530635951,"['CDKN1A', 'H2AFZ', 'CDK2']",0.9174889284201794,0,0,3
279,TYROBP causal network in microglia WP3945,0.6898845264276144,0.8410445922641044,0.3122218657368206,"['TNFRSF1B', 'C1QC']",0.9174889284201794,0,0,2
280,16p11.2 distal deletion syndrome WP4950,0.694405177550934,0.8568636295293941,0.3124978739386619,['PLN'],0.9174889284201794,0,0,1
281,Signal transduction through IL1R WP4496,0.694405177550934,0.8568636295293941,0.3124978739386619,['IL1B'],0.9174889284201794,0,0,1
282,Ethanol effects on histone modifications WP3996,0.694405177550934,0.8568636295293941,0.3124978739386619,['ADH1B'],0.9174889284201794,0,0,1
283,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.694405177550934,0.8568636295293941,0.3124978739386619,['GAL'],0.9174889284201794,0,0,1
284,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6971678115701166,0.8357391574438868,0.30147546297084465,"['TPO', 'NPY', 'DIO3']",0.9174889284201794,0,0,3
285,Pancreatic adenocarcinoma pathway WP4263,0.6971678115701166,0.8357391574438868,0.30147546297084465,"['CDKN1A', 'GADD45B', 'DUSP6']",0.9174889284201794,0,0,3
286,Endochondral Ossification with Skeletal Dysplasias WP4808,0.6990468890920768,0.8259775454897406,0.29573090137330355,"['SCIN', 'CALM1']",0.9174889284201794,0,0,2
287,Endochondral Ossification WP474,0.6990468890920768,0.8259775454897406,0.29573090137330355,"['SCIN', 'CALM1']",0.9174889284201794,0,0,2
288,Regulation of toll-like receptor signaling pathway WP1449,0.7068388191623358,0.8329905992949471,0.2890082688870688,"['CISH', 'IL1B', 'PELI3', 'IRF7']",0.9174889284201794,0,0,4
289,Sphingolipid pathway WP1422,0.7070839817504923,0.8262130291900251,0.2863702561031343,['SERINC1'],0.9174889284201794,0,0,1
290,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.7070839817504923,0.8262130291900251,0.2863702561031343,['IRF7'],0.9174889284201794,0,0,1
291,miRNAs involvement in the immune response in sepsis WP4329,0.7070839817504923,0.8262130291900251,0.2863702561031343,['IRF7'],0.9174889284201794,0,0,1
292,PDGFR-beta pathway WP3972,0.7070839817504923,0.8262130291900251,0.2863702561031343,['ELK1'],0.9174889284201794,0,0,1
293,SARS-CoV-2 mitochondrial interactions WP5038,0.7070839817504923,0.8262130291900251,0.2863702561031343,['IRF7'],0.9174889284201794,0,0,1
294,Proteasome Degradation WP183,0.7079835825604534,0.8114391670232491,0.28021783680838025,"['PSMB6', 'H2AFZ']",0.9174889284201794,0,0,2
295,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.7169376034048233,0.8312533646552146,0.27661324509658886,"['NTRK1', 'EGR1', 'EGR2', 'RAB3A', 'ELK1']",0.925337735913105,0,0,5
296,Toll-like Receptor Signaling related to MyD88 WP3858,0.7192374340398341,0.7976762633568195,0.26288517874292294,['IRF7'],0.925337735913105,0,0,1
297,3q29 copy number variation syndrome WP4906,0.7251918887739824,0.7838408892563502,0.2518629589189129,"['TM4SF19', 'DYNLL1']",0.925337735913105,0,0,2
298,G Protein Signaling Pathways WP35,0.7261187065173413,0.7971272165816684,0.2551140052490763,"['GNG3', 'PRKCH', 'CALM1']",0.925337735913105,0,0,3
299,Heart Development WP1591,0.7308872743596923,0.771041948579161,0.24171859644764546,['FOXC1'],0.925337735913105,0,0,1
300,G1 to S cell cycle control WP45,0.7334698064193116,0.7707317073170732,0.23890281785841314,"['CDKN1A', 'CDK2']",0.925337735913105,0,0,2
301,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.7334698064193116,0.7707317073170732,0.23890281785841314,"['PRKCH', 'CCL2']",0.925337735913105,0,0,2
302,p53 transcriptional gene network WP4963,0.7334698064193116,0.7707317073170732,0.23890281785841314,"['CDKN1A', 'CCL2']",0.925337735913105,0,0,2
303,Fatty acid beta-oxidation WP143,0.7420543442313325,0.7461259766903837,0.22259385050494376,['TPI1'],0.9269596890234023,0,0,1
304,Fluoropyrimidine Activity WP1601,0.7420543442313325,0.7461259766903837,0.22259385050494376,['CYP2A6'],0.9269596890234023,0,0,1
305,miRNA regulation of prostate cancer signaling pathways WP3981,0.7420543442313325,0.7461259766903837,0.22259385050494376,['CDKN1A'],0.9269596890234023,0,0,1
306,Alpha 6 Beta 4 signaling pathway WP244,0.7527586236499354,0.722767253044655,0.20527360130539782,['LAMB3'],0.9281586912965222,0,0,1
307,Disruption of postsynaptic signaling by CNV WP4875,0.7527586236499354,0.722767253044655,0.20527360130539782,['YWHAG'],0.9281586912965222,0,0,1
308,MAPK Cascade WP422,0.7527586236499354,0.722767253044655,0.20527360130539782,['ELK1'],0.9281586912965222,0,0,1
309,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.7527586236499354,0.722767253044655,0.20527360130539782,['TEAD2'],0.9281586912965222,0,0,1
310,Signaling of Hepatocyte Growth Factor Receptor WP313,0.763019266832925,0.7008242096198795,0.18955332323953847,['ELK1'],0.9365557979029631,0,0,1
311,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.7644851788656732,0.7223915989159891,0.19400017136664507,"['CDKN1A', 'DKK1']",0.9365557979029631,0,0,2
312,Target Of Rapamycin (TOR) Signaling WP1471,0.7728546363194386,0.6801719334553848,0.1752560247133384,['RRAGA'],0.9386986757386643,0,0,1
313,Genes controlling nephrogenesis WP4823,0.7728546363194386,0.6801719334553848,0.1752560247133384,['FOXC1'],0.9386986757386643,0,0,1
314,PI3K-Akt signaling pathway WP4172,0.7736256802675605,0.8181288254153308,0.20998678544227947,"['NTRK1', 'CDKN1A', 'HSP90AA1', 'GNG3', 'FLT1', 'VWF', 'LAMB3', 'CDK2', 'OSMR', 'EPHA2']",0.9386986757386643,0,0,10
315,MECP2 and Associated Rett Syndrome WP3584,0.7787847842141452,0.7004188223700418,0.1751190944016993,"['SST', 'FKBP5']",0.9419587390018708,0,0,2
316,Bladder cancer WP2828,0.7913192403805446,0.6423094271538115,0.15033496333316035,['CDKN1A'],0.946311040090293,0,0,1
317,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7913192403805446,0.6423094271538115,0.15033496333316035,['GABRE'],0.946311040090293,0,0,1
318,Oxysterols derived from cholesterol WP4545,0.7913192403805446,0.6423094271538115,0.15033496333316035,['CYP39A1'],0.946311040090293,0,0,1
319,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.7923181674246811,0.6797385620915033,0.15823786336181536,"['ACTB', 'ACTG1']",0.946311040090293,0,0,2
320,Thermogenesis WP4321,0.8053413494479604,0.6929715061058345,0.15002074640201277,"['ADCY10', 'ACTB', 'ACTG1']",0.9534256174905711,0,0,3
321,Genes related to primary cilium development (based on CRISPR) WP4536,0.8053413494479604,0.6929715061058345,0.15002074640201277,"['EVC2', 'EVC', 'DYNLL1']",0.9534256174905711,0,0,3
322,IL-5 signaling pathway WP127,0.8082847098410878,0.6084324478313511,0.12949932126177466,['ELK1'],0.9534256174905711,0,0,1
323,PDGF Pathway WP2526,0.8082847098410878,0.6084324478313511,0.12949932126177466,['ELK1'],0.9534256174905711,0,0,1
324,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.8238726074005892,0.5779431664411366,0.11197034131764631,['CISH'],0.9628695196920996,0,0,1
325,Development of ureteric collection system WP5053,0.8238726074005892,0.5779431664411366,0.11197034131764631,['FOXC1'],0.9628695196920996,0,0,1
326,DNA Replication WP466,0.8238726074005892,0.5779431664411366,0.11197034131764631,['CDK2'],0.9628695196920996,0,0,1
327,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.8340853023440628,0.6160433604336043,0.1117623405657977,"['KLF4', 'DKK1']",0.9694884554018965,0,0,2
328,Interleukin-11 Signaling Pathway WP2332,0.8381946506187662,0.5503576261357046,0.09714083179845384,['SOCS3'],0.9694884554018965,0,0,1
329,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.8393910617748739,0.6079018684923692,0.10643059378095293,"['CISH', 'CALM1']",0.9694884554018965,0,0,2
330,ATM Signaling Network in Development and Disease  WP3878,0.8449133939785672,0.5375271422727129,0.09058469174775059,['HSPB1'],0.9694884554018965,0,0,1
331,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.8449133939785672,0.5375271422727129,0.09058469174775059,['DHCR24'],0.9694884554018965,0,0,1
332,Prostaglandin Synthesis and Regulation WP98,0.8449133939785672,0.5375271422727129,0.09058469174775059,['HSD11B2'],0.9694884554018965,0,0,1
333,Toll-like Receptor Signaling Pathway WP75,0.8543982271432478,0.5847140749888512,0.09200937060918499,"['IL1B', 'IRF7']",0.9694884554018965,0,0,2
334,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8575265340431473,0.5135769057284619,0.07893839173692435,['EIF4A2'],0.9694884554018965,0,0,1
335,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.8575265340431473,0.5135769057284619,0.07893839173692435,['HSPA5'],0.9694884554018965,0,0,1
336,Histone Modifications WP2369,0.8575265340431473,0.5135769057284619,0.07893839173692435,['HIST1H3E'],0.9694884554018965,0,0,1
337,One-carbon metabolism and related pathways WP3940,0.8575265340431473,0.5135769057284619,0.07893839173692435,['GPX4'],0.9694884554018965,0,0,1
338,Pyrimidine metabolism WP4022,0.8636805149166167,0.5702097761718358,0.08356558438080618,"['POLR2I', 'POLR2K']",0.9735570301279023,0,0,2
339,TGF-beta Receptor Signaling WP560,0.8691151106068163,0.49166498718797685,0.06897061650510751,['FST'],0.9767930889120856,0,0,1
340,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8745514327061532,0.48139377537212447,0.06452803022280859,['CALM1'],0.9800120466501305,0,0,1
341,Translation Factors WP107,0.8847568902817308,0.46208389715832204,0.0565786484115983,['EIF4A2'],0.9814508346258565,0,0,1
342,ErbB signaling pathway WP673,0.8883640483908761,0.5306980656013457,0.06282067004416333,"['CDKN1A', 'ELK1']",0.9814508346258565,0,0,2
343,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8895443240528398,0.4529968956459444,0.0530214487438828,['FST'],0.9814508346258565,0,0,1
344,Cardiac Hypertrophic Response WP2795,0.8895443240528398,0.4529968956459444,0.0530214487438828,['CALM1'],0.9814508346258565,0,0,1
345,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.889585520057604,0.6873827583394503,0.08042353013451664,"['CDKN1A', 'HSP90AA1', 'GNG3', 'FLT1', 'VWF', 'LAMB3', 'OSMR', 'EPHA2']",0.9814508346258565,0,0,8
346,Interferon type I signaling pathways WP585,0.8941331319234067,0.4442593941917352,0.04971289176850865,['SOCS3'],0.9814508346258565,0,0,1
347,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.8941331319234067,0.4442593941917352,0.04971289176850865,['IRF7'],0.9814508346258565,0,0,1
348,Insulin Signaling WP481,0.8972142076094669,0.5988848108413326,0.0649554304466924,"['SOCS3', 'EGR1', 'PRKCH', 'ELK1']",0.9814508346258565,0,0,4
349,Genotoxicity pathway WP4286,0.9027474492077165,0.42775522477822886,0.04376468265556527,['CDKN1A'],0.9814508346258565,0,0,1
350,TGF-beta Signaling Pathway WP366,0.907027485638517,0.5491374297344447,0.0535862171987777,"['CDKN1A', 'PARD6A', 'CITED1']",0.9814508346258565,0,0,3
351,Ectoderm Differentiation WP2858,0.907027485638517,0.5491374297344447,0.0535862171987777,"['STC1', 'CCL2', 'LY6E']",0.9814508346258565,0,0,3
352,MET in type 1 papillary renal cell carcinoma WP4205,0.9106616798867033,0.4124299246085444,0.03859676904007166,['CDKN1A'],0.9814508346258565,0,0,1
353,Notch Signaling Pathway Netpath WP61,0.9106616798867033,0.4124299246085444,0.03859676904007166,['CDKN1A'],0.9814508346258565,0,0,1
354,Wnt signaling pathway and pluripotency WP399,0.9118992006759926,0.49097618635760826,0.04528068167736047,"['PRKCH', 'CD44']",0.9814508346258565,0,0,2
355,AGE/RAGE pathway WP2324,0.9307494445282057,0.37238639835872367,0.02672437058825571,['CYCS'],0.9923706544634532,0,0,1
356,AMP-activated protein kinase (AMPK) signaling WP1403,0.9307494445282057,0.37238639835872367,0.02672437058825571,['CDKN1A'],0.9923706544634532,0,0,1
357,Pathways affected in adenoid cystic carcinoma WP3651,0.9307494445282057,0.37238639835872367,0.02672437058825571,['INSRR'],0.9923706544634532,0,0,1
358,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9363873492140157,0.3607070365358593,0.0237078499740115,['RBP4'],0.9923706544634532,0,0,1
359,DNA damage response (only ATM dependent) WP710,0.9375637527209677,0.4435063581405045,0.028593085775354774,"['CDKN1A', 'BIK']",0.9923706544634532,0,0,2
360,Ciliopathies WP4803,0.9387401053456615,0.5325144508670521,0.03366376166335628,"['EVC2', 'RSPH4A', 'EVC', 'CCDC65']",0.9923706544634532,0,0,4
361,Ciliary landscape WP4352,0.940503415230793,0.5586817251172314,0.03426953643483279,"['NEFL', 'COPS7A', 'NEFM', 'CALM1', 'DYNLL1']",0.9923706544634532,0,0,5
362,Male infertility WP4673,0.9456953056337447,0.4269798253538091,0.02384035402316633,"['CYP26B1', 'ETV5']",0.9923706544634532,0,0,2
363,16p11.2 proximal deletion syndrome WP4949,0.9463250530629149,0.33940937674122423,0.018724930571054867,['ALDOA'],0.9923706544634532,0,0,1
364,Integrated breast cancer pathway WP1984,0.9493830828708495,0.47335551383803276,0.024587454229700486,"['CDK2', 'RHO', 'FAU']",0.9923706544634532,0,0,3
365,Head and Neck Squamous Cell Carcinoma WP4674,0.9506962962707622,0.32967330369224823,0.016668486439768287,['CDKN1A'],0.9923706544634532,0,0,1
366,Joubert Syndrome WP4656,0.9584009738578727,0.3117799802508869,0.013247230646773373,['ARR3'],0.9949980661688436,0,0,1
367,T-cell receptor (TCR) signaling pathway WP69,0.9617898368635729,0.3035396339292073,0.011825696814885144,['IL1B'],0.9949980661688436,0,0,1
368,DNA IR-damage and cellular response via ATR WP4016,0.9649029520705316,0.295721869470178,0.010565477170708182,['CDK2'],0.9949980661688436,0,0,1
369,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9716219645997003,0.27782578215432774,0.007998180717737316,['DKK1'],0.9949980661688436,0,0,1
370,Neural Crest Differentiation WP2064,0.9728029565607528,0.2745022230813841,0.007569049784823064,['MIA'],0.9949980661688436,0,0,1
371,Chemokine signaling pathway WP3929,0.9769117008225056,0.34885439763488546,0.00814889297641864,"['FGR', 'GNG3']",0.9949980661688436,0,0,2
372,B Cell Receptor Signaling Pathway WP23,0.9789264678081651,0.2561118628777627,0.00545486222281996,['ELK1'],0.9949980661688436,0,0,1
373,Regulation of Actin Cytoskeleton WP51,0.9814339182752234,0.3335689878637917,0.006251281243287734,"['ACTB', 'ACTG1']",0.9949980661688436,0,0,2
374,Breast cancer pathway WP4262,0.9827407250549267,0.32876500193573366,0.0057237830577959135,"['CDKN1A', 'GADD45B']",0.9949980661688436,0,0,2
375,Integrin-mediated Cell Adhesion WP185,0.9829631011446202,0.2425610711487786,0.004168095835062488,['RHO'],0.9949980661688436,0,0,1
376,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9839580442314976,0.3240963395549448,0.0052412927493570545,"['CLDN5', 'CLDN9']",0.9949980661688436,0,0,2
377,Wnt signaling WP428,0.98886660885041,0.21933114247052002,0.00245559445412854,['DKK1'],0.9949980661688436,0,0,1
378,ESC Pluripotency Pathways WP3931,0.98886660885041,0.21933114247052002,0.00245559445412854,['ELK1'],0.9949980661688436,0,0,1
379,Osteoblast differentiation WP4787,0.9897749792073273,0.21520620186410025,0.0022118151867067445,['PRKCH'],0.9949980661688436,0,0,1
380,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9950415160458467,0.18551660919289362,0.0009221693048760804,['TRIP10'],0.9976600463512304,0,0,1
381,EGF/EGFR signaling pathway WP437,0.9987841775475488,0.146238245865044,0.00017790791687868993,['ELK1'],0.9987841775475488,0,0,1
